Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Freed

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Journal of Psychiatric Research|March 4, 2000
Elevated concentration of N-CAM VASE isoforms in schizophreniaM P Vawter, M A Frye, J J Hemperly, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Dopaminergic differentiation of human embryonic stem cellsXianmin Zeng, Jingli Cai, Jia Chen, et al.
Emotion (Washington, D.C.)|September 6, 2019
Hurts so good: Pain as an emotion regulation strategyAshley M Doukas, Wendy M D'Andrea, Wesley E Gregory, et al.
Cell and Tissue Research|January 13, 2006
GABAergic lineage differentiation of AF5 neural progenitor cells in vitroJoseph F Sanchez, Daniel R Crooks, Chun-Ting Lee, et al.
Experimental Neurology|October 30, 2001
Characterization of human cleaved N-CAM and association with schizophreniaM P Vawter, N Usen, L Thatcher, et al.
Cell Transplantation|August 22, 2007
An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeB K Harvey, G J Chen, C J Schoen, et al.
Stem Cells and Development|November 25, 2005
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cellsCatherine M Schwartz, Charles E Spivak, Shawn C Baker, et al.
Experimental Neurology|January 6, 1999
VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophreniaM P Vawter, J J Hemperly, T M Hyde, et al.
Stem Cells (Dayton, Ohio)|November 19, 2005
Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell researchTodd W Plaia, Richard Josephson, Ying Liu, et al.
Addiction Biology|January 19, 2008
Postmortem diagnosis and toxicological validation of illicit substance useElin Lehrmann, Zoan R Afanador, Amy Deep-Soboslay, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Journal of Psychiatric Research|March 4, 2000
Elevated concentration of N-CAM VASE isoforms in schizophreniaM P Vawter, M A Frye, J J Hemperly, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Dopaminergic differentiation of human embryonic stem cellsXianmin Zeng, Jingli Cai, Jia Chen, et al.
Emotion (Washington, D.C.)|September 6, 2019
Hurts so good: Pain as an emotion regulation strategyAshley M Doukas, Wendy M D'Andrea, Wesley E Gregory, et al.
Cell and Tissue Research|January 13, 2006
GABAergic lineage differentiation of AF5 neural progenitor cells in vitroJoseph F Sanchez, Daniel R Crooks, Chun-Ting Lee, et al.
Experimental Neurology|October 30, 2001
Characterization of human cleaved N-CAM and association with schizophreniaM P Vawter, N Usen, L Thatcher, et al.
Cell Transplantation|August 22, 2007
An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeB K Harvey, G J Chen, C J Schoen, et al.
Stem Cells and Development|November 25, 2005
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cellsCatherine M Schwartz, Charles E Spivak, Shawn C Baker, et al.
Experimental Neurology|January 6, 1999
VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophreniaM P Vawter, J J Hemperly, T M Hyde, et al.
Stem Cells (Dayton, Ohio)|November 19, 2005
Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell researchTodd W Plaia, Richard Josephson, Ying Liu, et al.
Addiction Biology|January 19, 2008
Postmortem diagnosis and toxicological validation of illicit substance useElin Lehrmann, Zoan R Afanador, Amy Deep-Soboslay, et al.
Pageof 31